Artificial Axon Labs is excited to celebrate the @MassChallenge Early Stage program! Join us on Sept. 21 to see us pitch at the #StartupShowcase! Attendees can cast a first round vote to select a finalist for a $25k cash prize! #MC22 Register: cvent.me/rDPdaV
As a supporter of #MassBioDrive, we’re excited to share the 5 emerging biotech companies selected for the spring 2022 cohort. Congrats to @ArtificialAxons , Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget Biosciences, & @SYTEbio - bit.ly/360dHLj
As a curriculum expert for #MassBioDrive, #KPMGBoston is excited to share the emerging biotech companies selected for the spring 2022 cohort. Congrats to Artificial Axon Labs, @Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget... bit.ly/37WoAyF
As a curriculum expert for #MassBioDrive, #KPMGBoston is excited to share the emerging biotech companies selected for the spring 2022 cohort. Congrats to Artificial Axon Labs, @Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget... bit.ly/3IArrKg
Two biotech startups from the Bay State, two from Canada and one from California will take part in MassBio's first installment of its accelerator program MassBioDrive. bizjournals.com/boston/news/…
We are pleased to announce the five emerging startups chosen to participate in the #MassBioDrive spring 2022 cohort: Artificial Axon Labs, Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget Biosciences, and SYTE.bio. (1/3)
Are you in the Boston area? Want to connect with the @MassBio ecosystem, learn about these new startups, and meet with some of our team?
Register to join the community mixer on March 30th: massbio.org/events/listing/m…
As a supporter of #MassBioDrive, we’re excited to share the five emerging biotech companies selected for the spring 2022 cohort. We can’t wait to help these companies grow over the next 8 weeks – learn more about them here: bit.ly/360dHLj
Two biotech startups from the Bay State, two from Canada and one from California will take part in MassBio's first installment of its accelerator program MassBioDrive. bizjournals.com/boston/inno/…
We are pleased to announce the five emerging startups chosen to participate in the #MassBioDrive spring 2022 cohort: Artificial Axon Labs, Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget Biosciences, and SYTE.bio. (1/3)
As a curriculum expert for #MassBioDrive, #KPMGBoston is excited to share the emerging biotech companies selected for the spring 2022 cohort. Congrats to Artificial Axon Labs, @Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget... bit.ly/3qt52bh
We are pleased to announce the five emerging startups chosen to participate in the #MassBioDrive spring 2022 cohort: Artificial Axon Labs, Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget Biosciences, and SYTE.bio. (1/3)
Congratulations to the 5 emerging biotech companies selected for the #MassBioDrive spring cohort!
We're proud to partner with @MassBio as curriculum experts to support new generations of entrepreneurs. massbio.org/news/recent-news…
ALT MassBioDrive List of Selected companies for the Spring 2022 cohort. Artificial Axon Labs, Atorvia Health Technologies, Modulari-T Biosciences, PhenoTarget Biosciences, and SYTE.bio
Join us on March 30 for a Networking Mixer and meet the cohort startups and connect with MassBio's innovation ecosystem. Register: bit.ly/37e6YO5 (3/3)